Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.3 Billion CNY | -6.34% |
| 2022 | 2.46 Billion CNY | 36.4% |
| 2021 | 1.8 Billion CNY | 15.24% |
| 2020 | 1.56 Billion CNY | 3.81% |
| 2019 | 1.5 Billion CNY | 19.44% |
| 2018 | 1.26 Billion CNY | 12.22% |
| 2017 | 1.12 Billion CNY | 30.79% |
| 2016 | 860.72 Million CNY | 29.93% |
| 2015 | 662.44 Million CNY | 10.04% |
| 2014 | 602 Million CNY | 31.12% |
| 2013 | 459.13 Million CNY | 32.02% |
| 2012 | 347.77 Million CNY | 8.98% |
| 2011 | 319.1 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.67 Billion CNY | 16.11% |
| 2024 Q2 | 2.8 Billion CNY | 4.7% |
| 2024 Q3 | 2.99 Billion CNY | 6.87% |
| 2023 FY | 2.3 Billion CNY | -6.34% |
| 2023 Q1 | 2.69 Billion CNY | 9.57% |
| 2023 Q3 | 2.69 Billion CNY | 3.03% |
| 2023 Q4 | 2.3 Billion CNY | -14.46% |
| 2023 Q2 | 2.61 Billion CNY | -3.0% |
| 2022 Q4 | 2.46 Billion CNY | 20.74% |
| 2022 Q2 | 1.93 Billion CNY | 4.75% |
| 2022 Q1 | 1.84 Billion CNY | 2.08% |
| 2022 Q3 | 2.03 Billion CNY | 5.64% |
| 2022 FY | 2.46 Billion CNY | 36.4% |
| 2021 FY | 1.8 Billion CNY | 15.24% |
| 2021 Q1 | 1.77 Billion CNY | 13.16% |
| 2021 Q2 | 1.8 Billion CNY | 1.92% |
| 2021 Q3 | 1.89 Billion CNY | 4.73% |
| 2021 Q4 | 1.8 Billion CNY | -4.6% |
| 2020 Q4 | 1.56 Billion CNY | 0.42% |
| 2020 Q1 | 1.61 Billion CNY | 7.31% |
| 2020 FY | 1.56 Billion CNY | 3.81% |
| 2020 Q2 | 1.47 Billion CNY | -9.16% |
| 2020 Q3 | 1.55 Billion CNY | 6.05% |
| 2019 Q2 | 1.46 Billion CNY | -4.25% |
| 2019 FY | 1.5 Billion CNY | 19.44% |
| 2019 Q4 | 1.5 Billion CNY | -6.79% |
| 2019 Q3 | 1.61 Billion CNY | 10.54% |
| 2019 Q1 | 1.52 Billion CNY | 21.07% |
| 2018 Q1 | 1.43 Billion CNY | 27.51% |
| 2018 Q4 | 1.26 Billion CNY | -1.78% |
| 2018 FY | 1.26 Billion CNY | 12.22% |
| 2018 Q3 | 1.28 Billion CNY | 14.75% |
| 2018 Q2 | 1.12 Billion CNY | -21.91% |
| 2017 Q4 | 1.12 Billion CNY | 4.48% |
| 2017 FY | 1.12 Billion CNY | 30.79% |
| 2017 Q3 | 1.07 Billion CNY | 5.77% |
| 2017 Q2 | 1.01 Billion CNY | 4.04% |
| 2017 Q1 | 979.21 Million CNY | 13.77% |
| 2016 FY | 860.72 Million CNY | 29.93% |
| 2016 Q4 | 860.72 Million CNY | 12.14% |
| 2016 Q2 | 833.55 Million CNY | 13.97% |
| 2016 Q1 | 731.35 Million CNY | 10.4% |
| 2016 Q3 | 767.53 Million CNY | -7.92% |
| 2015 Q2 | 637.39 Million CNY | -0.84% |
| 2015 Q4 | 662.44 Million CNY | -9.27% |
| 2015 Q3 | 730.13 Million CNY | 14.55% |
| 2015 Q1 | 642.76 Million CNY | 6.77% |
| 2015 FY | 662.44 Million CNY | 10.04% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 555.64 Million CNY | 11.93% |
| 2014 Q4 | 602 Million CNY | 8.34% |
| 2014 FY | 602 Million CNY | 31.12% |
| 2014 Q2 | 496.44 Million CNY | 0.0% |
| 2013 FY | 459.13 Million CNY | 32.02% |
| 2013 Q4 | 459.13 Million CNY | 0.0% |
| 2012 FY | 347.77 Million CNY | 8.98% |
| 2011 FY | 319.1 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 6.23 Billion CNY | 62.996% |
| Liaoning Cheng Da Co., Ltd. | 1.69 Billion CNY | -36.013% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 36.62 Billion CNY | 93.703% |